Reactions Weekly

, Volume 622, Issue 1, pp 6–6 | Cite as

Thromboembolic events occurred in 10% of patients receiving epirubicin + cyclophosphamide

Incidence study
  • 5 Downloads

Keywords

Breast Cancer High Risk Cyclophosphamide Adjuvant Therapy Deep Vein Thrombosis 

Copyright information

© Adis International limited or Adis Data Information BV 1996

Personalised recommendations